home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Bayer and MOMA Therapeutics enter collaboration and license agreement in Oncology
Bayer and MOMA Therapeutics enter collaboration and license agreement in Oncology
Post navigation
Previous Post
Previous
Revolution Medicines to Deliver Multiple Presentations at the 2024 EORTC-NCI-AACR Symposium and Host Investor Webcast
Next Post
Next
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended to Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer